Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Cell culture studies demonstrate that GLP3 exhibits differential potency across its three target receptors: it is approximately 8.9-fold more potent at the human GIP receptor (EC50: 0.0643 nM) compared to the endogenous GIP ligand, while showing reduced potency at GLP-1 receptors (0.4-fold, EC50: 0.775 nM) and glucagon receptors (0.3-fold, EC50: 5.79 nM) relative to their native hormones[3]
The product has been developed and formulated in-house, allowing the company to focus on maintaining reliable supply and consistent quality standards for patients across India
What support is available for side effects
Fogel ELS, S
US$ 28.76
US$ 20.71
US$ 23.74
US$ 29.29
US$ 23.72
